Dupilumab and Cutaneous T-Cell Lymphoma: What is the Link?
Unable to add items
Sorry, we're unable to add the item because your cart is already full.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Failed to remove from Wish List.
Please try again later
Adding to library failed
Please try again
Unable to follow podcast
Unable to unfollow podcast
-
Narrated by:
-
By:
Summary
In this episode we unpack the recent internet chatter related to the relationship between dupilumab and a rare type of skin cancer -- cutaneous T-cell lymphoma -- with two leading experts: Dr. Lawrence Eichenfield (director of the Rady Children's UC San Diego Eczema and Inflammatory Skin Disease Center) and Dr. Peter Lio (director of the Chicago Integrative Eczema Center).
We dig into the evidence and probabilities, and weigh the risks of treatment against the costs of leaving moderate-to-severe eczema uncontrolled. If your child is taking dupilumab (or you're considering it), this podcast will help you make the best treatment decisions for your child.
adbl_web_anon_alc_button_suppression_t1
No reviews yet